This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Amunix Pharmaceuticals, Inc. Active years: 2026.
Company Filing History:
Years Active: 2026
Title: Tracy Young: Innovator in Antibody Therapeutics
Introduction
Tracy Young is a notable inventor based in Belmont, CA (US). He has made significant contributions to the field of antibody therapeutics, particularly in the development of compositions targeting the epidermal growth factor receptor (EGFR). His innovative work has the potential to impact cancer treatment and other medical applications.
Latest Patents
Tracy Young holds 1 patent for his invention titled "Compositions targeting epidermal growth factor receptor and methods for making and using the same." This patent describes antibody binding domains for the cluster of differentiation 3 T cell receptor (CD3) and the epidermal growth factor receptor (EGFR). It also includes cleavable linker sequences and protease-activatable bispecific fusion proteins, such as protease-activatable T cell engagers, along with their uses and methods of treatment.
Career Highlights
Tracy Young is currently associated with Amunix Pharmaceuticals, Inc., where he continues to advance his research in antibody therapeutics. His work is characterized by a commitment to developing innovative solutions for complex medical challenges.
Collaborations
Tracy collaborates with talented professionals in his field, including Viktoriya Dubrovskaya and Eric Johansen. These collaborations enhance the research and development efforts at Amunix Pharmaceuticals, Inc.
Conclusion
Tracy Young's contributions to the field of antibody therapeutics exemplify the spirit of innovation in medical research. His work has the potential to lead to significant advancements in treatment methodologies.